Bee Vectoring Technologies Announces Ongoing 2022 Almond Trials in California; Disease and Yield Data to Come
Retrieved on:
Thursday, March 31, 2022
Adoption, Company, University, Clonostachys, Sale, Monilinia laxa, Botrytis, Pathology, Plant pathology, Flower, Environment, Monilinia, Soil, J. E. M. Ag Supply, Inc. v. Pioneer Hi-Bred International, Inc., BVT, Health, CVE, Bee, Industry, Farmer, Crop protection, Autumn, Season, EPA, News, Pollination, Awareness, Tree, Almond, Disease, CSE, Beekeeping, Agriculture, Silviculture, Microbiology
This is the second year for BVT almond trials as farmers require multi-year data under local conditions for proof of efficacy.
Key Points:
- This is the second year for BVT almond trials as farmers require multi-year data under local conditions for proof of efficacy.
- Four R&D trials are being conducted to gather further disease and nut rot data, and to determine nutmeal quality.
- Across the eight trials, four varieties of almonds are being treated with BVT's proprietary Vectorite with CR-7 (Clonostachys rosea CR-7) biological fungicide, applied with bee vectoring.
- At minimum, the yield data obtained will be extremely valuable in initiating the sales process with almond growers.